SEC Filing Update: #SYRE Spyre Therapeutics, Inc. : $89.93

Sector: Healthcare | YTD: 🔼+ 193.79% The SEC disclosed Today (01-OCT-2026) that Paradigm Biocapital Advisors LP has INCREASED #SYRE Shares by 16.06% 🟢 * Previous Holdings: 3.84M Shares * Current Holdings: 4.46M Shares * Increase+616.67K * Increased(%)+16.06% * Ownership: 5.1% * Estimated Investment Value: $54.54M https://www.thinksabio.com/reports/isr/SYRE Institutional ownership in #SYRE has been steadily rising over the past 14 quarters in Shares: Q1 2024: 32.38M Q2 2024: 50.39M Q3 2024: 51.38M Q4 2024: 59.88M Q1 2025: 62.11M Q2 2025: 63.62M Q3 2025: 64.30M Q4 2025: 80.98M Q1 2026: 82.65M Q2 2026: 89.87M The quarterly average prices of #SYRE: Q3 2025: $16.30 Q4 2025: $26.02 Q1 2026: $37.69 Q2 2026: $73.00 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2105752414032630074